发明名称 MODULATION OF TELOMERE LENGTH IN TELOMERASE POSITIVE CELLS AND CANCER THERAPY
摘要 PROBLEM TO BE SOLVED: To contribute to the field of cancer therapy, particularly to enable regulation of telomere elongation in telomerase positive cells.SOLUTION: Induction of telomere shortening, G2 arrest and apoptosis in telomerase positive cancer cells using acyclic nucleoside analogs is disclosed. Also disclosed are methods for impairing or preventing a chance for tumorigenic telomerase positive cells to grow into a tumor and methods for promoting tumor regression (decrease in size of an established tumor) using acyclic nucleoside analogs.
申请公布号 JP2013224953(A) 申请公布日期 2013.10.31
申请号 JP20130133614 申请日期 2013.06.26
申请人 ALT SOLUTIONS INC 发明人 IGOR E BONDAREV
分类号 G01N33/50;A61K31/522;A61P35/00;A61P35/02;A61P43/00;G01N33/15 主分类号 G01N33/50
代理机构 代理人
主权项
地址